Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Tracon Pharmaceuticals Inc (TCON)

Tracon Pharmaceuticals Inc (TCON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Tracon: Q2 Earnings Snapshot AP - Tue Aug 13, 2024

Tracon: Q2 Earnings Snapshot

TCON : 0.0322 (-25.98%)
Tracon: Q1 Earnings Snapshot AP - Tue May 14, 2024

Tracon: Q1 Earnings Snapshot

TCON : 0.0322 (-25.98%)
Tracon: Q4 Earnings Snapshot AP - Tue Mar 5, 2024

Tracon: Q4 Earnings Snapshot

TCON : 0.0322 (-25.98%)
Tracon: Q3 Earnings Snapshot AP - Thu Nov 9, 2023

Tracon: Q3 Earnings Snapshot

TCON : 0.0322 (-25.98%)
Tracon: Q2 Earnings Snapshot AP - Mon Aug 14, 2023

Tracon: Q2 Earnings Snapshot

TCON : 0.0322 (-25.98%)
Tracon: Q1 Earnings Snapshot AP - Wed May 10, 2023

Tracon: Q1 Earnings Snapshot

TCON : 0.0322 (-25.98%)
Tracon: Q4 Earnings Snapshot AP - Wed Mar 8, 2023

Tracon: Q4 Earnings Snapshot

TCON : 0.0322 (-25.98%)
Tracon: Q3 Earnings Snapshot AP - Mon Nov 14, 2022

Tracon: Q3 Earnings Snapshot

TCON : 0.0322 (-25.98%)
US FDA Approval of IND for CTLA-4 Antibody YH001 for the Treatment of Front-line Sarcoma Patients in Combination with Envafolimab Business Wire - Mon Aug 29, 2022

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen") and TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), today jointly announced that the U.S. Food and Drug Administration (FDA) has approved the...

TCON : 0.0322 (-25.98%)
TRACON Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update Globe Newswire - Wed Aug 10, 2022

SAN DIEGO, Aug. 10, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a...

TCON : 0.0322 (-25.98%)

Barchart Exclusives

A Brown-Forman Acquisition Could Be Brewing. Does That Mean You Should Buy the Dividend Stock Here? Barchart - Tue Apr 14, 6:30PM CDT
Brown‑Forman is suddenly at the center of a potential bidding war, with both Pernod Ricard and privately held Sazerac reportedly circling the Jack Daniel's maker, sending shares up roughly 12% intraday and raising the question of whether that M&A premium is now fully baked into the price or still has room to run. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.